ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01399840
Recruitment Status : Completed
First Posted : July 22, 2011
Last Update Posted : September 15, 2017
Sponsor:
Collaborator:
Medivation, Inc.
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 31, 2014
  Actual Study Completion Date : May 31, 2014